Discovery Funding Opportunities
Patient Safety Learning Laboratories: Pursuing safety in diagnosis & treatment at the intersection of design, systems engineering, & health services research
Due Date: 02-26-2018
Applicants will select the area of diagnostic treatment focus they consider of high significance, a flexible methodology- problem analysis, design, development, implantation, and evaluation- is required that parallels a systems engineering process to give an underlying structure to the work undertaken. Applications that address the diagnostic as well as the treatment sides of medicine are welcomed.
Georgia CTSA Request for Proposals: Pilot Translational & Clinical Studies-Due March 1
Due Date: 03-01-2018
Georgia CTSA¿s Pilot Grants program is soliciting proposals that either generate preliminary data and refine research strategies for subsequent extramural grant applications or develop the best approaches and methodologies to address complex translational and clinical research problems. Two categories of grants will be considered: Grants that focus on translational and clinical research and grants that address a translational research question which could provide insights generalizable to other projects/diseases.
Georgia CTSA Request for Proposals: Biostatistics, Epidemiology, & Research Design-Due March 1
Due Date: 03-01-2018
Georgia CTSA¿s Biostatistics, Epidemiology, & Research Design (BERD) program is soliciting proposals to support novel methodological research in biostatistics, epidemiology, or health economics to advance clinical and translational research (CTR). Review criteria include: (i.) quantitative methodological research to fill gaps in CTR; (ii.) innovation; (iii.) feasibility; and (iv.) plans for dissemination of results. Awardees are encouraged to disseminate any software developed in their research to CTSpedia, an online knowledge base for CTR, as well as other relevant publicly available software repositories.
Collaborative Innovation Award, CTSA Program
Due Date: 03-08-2018
The purpose of this funding opportunity announcement (FOA) is to invite applications to stimulate innovative collaborative research in the NCATS¿ Clinical and Translational Science Award (CTSA) consortium. PAR-15-173 encourages X02 pre-applications for the CTSA Innovation Award Program.
Harold Amos Medical Faculty Development Program-Due March 12
Due Date: 03-12-2018
The program supports basic/biomedical, clinical, dental, nursing, and health services/epidemiology research. The purpose of the award is to facilitate the transition of a newly-trained clinician who wishes to develop into an independent investigator. Four-year postdoctoral research awards are offered to historically disadvantaged physicians, dentists, and nurses who are committed to developing careers in academic medicine and to serving as role models for students and faculty of similar background. Applications are due the second week of March.
Winship Invest$ Prostate Cancer Research Pilot Grant-Due March 14
Due Date: 03-14-2018
Winship has issued a unique prostate cancer funding opportunity that might be of interest to Emory faculty.
Robert Wood Johnson Foundation Interdisciplinary Research Leaders Program
Due Date: 03-14-2018
This is a leadership development opportunity for teams of researchers and community partners-including organizers, advocates, or other community champions. These teams use the power of applied research, research that informs and supports critical work being done in communities, to advance health and equity. The two themes for the 2018 program are 1.) Solutions for better health care delivery in rural America and 2.) Addressing the social and economic determinants to prevent chronic conditions and to promote health, wellbeing, and equity in rural America.
ResMed Foundation clinical research grant
Due Date: 03-15-2018
Funding will fall into the following categories: clinical research, physician, and public awareness of the hazards of sleep-disordered breathing, and community philanthropic involvement. The primary focuses of foundation grants are sleep and breathing, with limited funds available for community support.
Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)
Due Date: 03-17-2018
This FOA invites grant applications for EHSCC. As intellectual hubs for environmental health research, the EHSCC is expected to be the thought leaders for the field and advance the goals of the NIEHS Strategic Plan. The Core Centers provide critical research infrastructure, shared facilities, services and/or resources, to groups of investigators conducting environmental health sciences research.
Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 Clinical Trial Optional)
Due Date: 03-19-2018
The objective of this FOA is to support the development of new and innovative multipurpose prevention technologies with rheological/biophysical properties and product user perceptions compatible with current long-acting reversible contraceptive strategies for the dual purpose of preventing pregnancy and HIV infection in women.
Cystic Fibrosis Foundation clinical research awards
Due Date: 03-23-2018
The intent of funding from Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) is to provide support for investigator-initiated clinical research projects that have the potential to make an important contribution to the Cystic Fibrosis Foundation's mission.
Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer¿s Disease Risk (R01-Clinical Trial Not Allowed)
Due Date: 03-26-2018
This FOA invites comprehensive, cross-disciplinary studies aimed at building predictive molecular models of cognitive resilience based on high-dimensional molecular data collected in individuals who remain free of dementia despite being at high risk for Alzheimer¿s disease.
Human Frontier Science Program Grants
Due Date: 03-28-2018
Grants are awarded to teams of independent researchers at any stage of their careers. The research team is expected to develop new lines of research through the collaboration. Up to $450,000 per grant per year may be applied for. Applications including independent investigators early in their careers are encouraged.
Women & Minorities in STEM Fields
Due Date: 03-28-2018
The U.S. Department of Agriculture, National Institute of Food and Agriculture is seeking applications for a program that supports research and extension projects that have robust collaborations to increase the participation of women and underrepresented minorities from rural areas in science, technology, engineering, and mathematics fields that are relevant to USDA priorities identified by the Secretary.
Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
Due Date: 03-30-2018
This FOA solicits applications from single institutions or consortia of institutions to participate. The purpose of this program is to support multidisciplinary translational research centers focused on generating, validating, and advancing medical countermeasures to select NIAID Emerging Infectious Diseases/Pathogens.
Bioengineering Research Partnerships
Due Date: 05-08-2018
The goal of a Bioengineering Research Partnership (BRP) is to drive the development and speed the adoption of promising tools and technologies that can address important biomedical problems for which insufficient or no solutions exist. The use of engineering principles is encouraged to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need. A synergistic partnership between engineering and the life, physical, and computational sciences is also encouraged, where the unique skills of each discipline combine to enhance our understanding of life science processes or the practice of medicine.
Strategies to increase delivery of guideline-based care to populations with health disparities (R01 clinical trial optional)
Due Date: 05-18-2018
This FOA invites applications to conduct innovative and feasible studies to test strategies to accelerate the adoption of guideline-based recommendations into clinical practice among populations with health disparities.
Shared Instrumentation for Animal Research (SIFAR) Grant Program
Due Date: 05-31-2018
The program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH.
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
Due Date: 05-31-2018
The objective of the program is to make available to institutions expensive research instruments that can only be justified on a shared-use basis and that are needed for NIH-supported projects in basic, translational, or clinical areas of biomedical/behavioral research.
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Due Date: 05-31-2018
The objective of the program is to make available to institutions expensive research instruments that can only be justified on a shared-use basis and that are needed for NIH-supported projects in basic, translational, or clinical areas of biomedical and bio-behavioral research.
Georgia Center for Diabetes Translation Research Small Grant Awards (GCDTR-03)
Due Date: 05-31-2018
The Georgia Center for Diabetes Translation Research (Georgia CDTR) is a collaboration of Emory University, Georgia Tech, and Morehouse School of Medicine, with funding provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and interinstitutional partners. The mission of the center is to facilitate and grow diabetes translation research at Emory, its partner institutions, and regionally. In alignment with this mission, this is a solicitation for small grant proposals that focus on Type II translation research in diabetes care and prevention.
Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed)
Due Date: 06-20-2018
The RIVER program seeks to provide support for the majority of the independent research program for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts.
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
Due Date: 06-20-2018
The award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers, and who plan to make a long-term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders.
Image-guided Drug Delivery (R01 Clinical Trial Optional)
Due Date: 06-21-2018
This FOA will support innovative research projects that are focused on image-guided drug delivery, including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response. It will support research in development of integrated imaging-based systems for delivery of drugs or biologics in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.
Biomarkers: Bridging Pediatric & Adult Therapeutics (R21)
This FOA encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy.
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
Due Date: 12-31-2017
NIH is offering funding for administrative supplements to encourage and improve the diversity of the research workforce. This funding can help recruitment efforts and support for students, postdoctorates and eligible investigators from groups that have been underrepresented in health-related research.
Research on the Health of Transgender & Gender Nonconforming Populations (R01)
Due Date: 12-29-2017
This FOA calls for research on the health of transgender and gender nonconforming people of all ages, who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.
Society of General Internal Medicine (SGIM) Founder's Grants
The grant will support research by a junior investigator. Applicants are encouraged to consider using the SGIM Research Dataset Compendium for their proposed research projects. This resource provides information about a number of public use datasets and provides opportunities from investigators to get mentoring and one-time consultation from senior SGIM members who are experienced in accessing and using the datasets.
NIA Academic Leadership Career Award (K07)
The objective of the award is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.
NIH Grants on Primary Immunodeficiency Diseases (R03/R21)
This FOA will support small grants on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases.
NIH Commons Credits Model
The NIH Commons Credits Model is a time- and cost-efficient way for NIH-funded biomedical investigators to gain cloud computing support for their current research as well as pave the way toward better accessibility, interoperability, and reuse of digital objects for future research. This is not a grant; this funding is recommended to supplement current NIH grants or to jump start a related grant in the biomedical space.
Advancing the Science of Geriatric Palliative Care (R01 & R21)
This FOA encourages exploratory or developmental research grant applications to develop new tools, methods, and models focused on palliative care in geriatric populations. The request for applications covers studies in a variety of healthcare or community settings. R01 and R21 available
RJWF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health
Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.
Ethical, Legal, & Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
This FOA invites R01 applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.
Small Grants for Secondary Analyses of Existing Data Sets & Stored Biospecimens (R03)
This FOA encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources.
NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 and UG3/UH3)
The program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. X02, UG3/UH3, and pediatric UG3/UH3 available.
Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.